Hi, Shrewd!        Login  
Shrewd'm.com 
A merry & shrewd investing community
Best Of BRK.A | Best Of | Favourites & Replies | All Boards | Post of the Week!
Search BRK.A
Shrewd'm.com Merry shrewd investors
Best Of BRK.A | Best Of | Favourites & Replies | All Boards | Post of the Week!
Search BRK.A


Stocks A to Z / Stocks B / Berkshire Hathaway (BRK.A)
Unthreaded | Threaded | Whole Thread (5) |
Author: rnam   😊 😞
Number: of 15059 
Subject: Re: Pfizer PFE at 34.30
Date: 09/06/2023 7:01 PM
Post New | Post Reply | Report Post | Recommend It!
No. of Recommendations: 1
Shares of Pfizer (NYSE:PFE) hit a 52-week low on Wednesday after rival Moderna (MRNA) said its updated COVID-19 vaccine had been shown to generate a 'strong' immune response against the BA.2.86 variant in human studies.

Pfizer shares closed down 3% at $34.37. The shares hit a 52-week low of $34.26 earlier in the day and were down 33% year-to-date as of market close Wednesday.

According to Reuters, Pfizer said that their updated COVID-19 vaccine also elicits a strong response to the variant. The Pfizer data, however, was based on studies involving mice. Pfizer's partner on the vaccine is BioNTech (BNTX).


https://seekingalpha.com/news/4009707-pfizer-stock...
Post New | Post Reply | Report Post | Recommend It!
Print the post
Unthreaded | Threaded | Whole Thread (5) |


Announcements
Berkshire Hathaway FAQ
Contact Shrewd'm
Contact the developer of these message boards.

Best Of BRK.A | Best Of | Favourites & Replies | All Boards | Followed Shrewds